Digoxin Toxicity: When Potassium Tells You How Sick the Heart Is

Part of the ICU Emergencies Hub — browse every related guide in one place.

Digoxin has a famously narrow therapeutic window, so toxicity is common and shows up in two very different patients. One is the deliberate or accidental acute overdose — a large single ingestion in a previously stable person. The other, seen more often in the ICU, is the chronic toxicity of an older patient on a steady dose whose kidneys have quietly declined, whose potassium has drifted, or who started an interacting drug like amiodarone or verapamil. Recognizing which story you are in changes what the potassium means and how aggressively you reach for the antidote.

The Mechanism: Poisoning the Sodium-Potassium Pump

Digoxin inhibits the Na-K-ATPase pump. Therapeutically this raises intracellular calcium and strengthens contraction, which is the point in heart failure, and it slows AV conduction, which is the point in atrial fibrillation. In toxicity those same actions run away. Blocking the pump means potassium can't be driven back into cells, so in acute overdose serum potassium rises — and that hyperkalemia is a direct readout of how much pump is poisoned, which is why the potassium level, historically, predicted survival better than the digoxin level. Meanwhile the calcium-loaded, electrically unstable myocardium becomes both irritable (ectopy, ventricular arrhythmias, the classic bidirectional ventricular tachycardia) and slow to conduct (sinus bradycardia, AV blocks). The paradox of a fast, ectopic rhythm sitting on a blocked, slow conduction system is the fingerprint.

Recognizing It

Early symptoms are deceptively nonspecific: nausea, vomiting, anorexia, fatigue, and confusion. The visual disturbances are classic and worth knowing — blurred or yellow-green vision and halos around lights (the "van Gogh" association). The cardiac findings are where danger lives: almost any dysrhythmia can occur, but the highly suggestive ones are those that combine enhanced automaticity with impaired conduction, such as atrial tachycardia with block, junctional rhythms, and bidirectional ventricular tachycardia. In the chronic patient the presentation is often just a slow decline into confusion and arrhythmia, easy to attribute to age or the underlying heart disease until someone checks a level and a potassium.

The Antidote: Digoxin-Specific Antibody Fragments

Digoxin immune Fab (DigiFab) binds digoxin and pulls it off the pump, reversing the toxicity — often within tens of minutes. It is the treatment for serious poisoning, and its indications are worth carrying: life-threatening arrhythmias, hemodynamic instability, significant hyperkalemia in acute toxicity (a potassium above roughly 5 mEq/L is a classic threshold), and large known ingestions. Dosing can be calculated from the ingested amount or the serum level, or given empirically for an unstable crashing patient. Two bedside consequences follow that nurses should anticipate. First, once Fab is given, standard digoxin assays become unreliable because they measure bound plus free drug — so a "high level" after Fab does not mean treatment failure. Second, in a patient who genuinely needs digoxin's effect (rate control, inotropy), reversing it can unmask the underlying condition, so the heart failure or atrial fibrillation may need other management afterward.

Supportive Care and the Potassium Nuance

Beyond the antidote, care is supportive and rhythm-focused. Atropine is tried for symptomatic bradycardia. Magnesium can help suppress digoxin-related tachyarrhythmias and is often low in the chronic patient. Temporary pacing is used cautiously because the poisoned myocardium is irritable and pacing can provoke arrhythmia — Fab is preferred when available. The potassium requires a divided mind: in acute toxicity you are watching a high potassium that the antidote will correct, so aggressive potassium-lowering measures are usually unnecessary and can overshoot into hypokalemia as Fab takes effect. In chronic toxicity the patient is frequently potassium- and magnesium-depleted, which itself worsens digoxin binding and arrhythmia, so gentle repletion is part of the fix — a genuinely opposite move depending on the story. Managing electrolytes here means knowing which scenario you are in; the general principles are in our hyperkalemia emergency guide and IV potassium replacement guide, applied with digoxin-specific caution.

The Nursing Priorities

Continuous telemetry is non-negotiable — the arrhythmias evolve and the bidirectional VT or new high-grade block can appear abruptly. Serial potassium and magnesium, a digoxin level (interpreted in light of acute vs chronic and whether Fab has been given), and renal function anchor the picture. Anticipate and set up for Fab so it is ready before the patient decompensates, and be the voice that questions a reflexive calcium push for digoxin hyperkalemia. Screen for the interacting drugs — amiodarone, verapamil, diltiazem, macrolides, and worsening renal function — that pushed a chronic patient over the edge, because fixing the precipitant prevents the bounce-back.

The Bottom Line

Digoxin toxicity is a poisoned sodium-potassium pump producing a heart that is at once too irritable and too blocked. Potassium is the storyteller: high and prognostic in acute overdose, often low and contributory in chronic toxicity. The antidote, DigiFab, is fast and definitive and is the right answer for digoxin-driven hyperkalemia — while a reflexive IV calcium push is the classic mistake to avoid. For the ICU nurse, the work is continuous rhythm surveillance, electrolyte interpretation that flips with the clinical story, and having the antibody ready before the rhythm declares an emergency.

Related: Beta-blocker overdose | Calcium-channel-blocker overdose | Hyperkalemia emergency | Atrial fibrillation with RVR | Unstable bradycardia